English
Osteoclasts (OCLs) are multinucleated giant cells responsible for bone resorption throughout life and whose function is highly deregulated in bone diseases such as osteoporosis or periodontitis. They arise from the fusion of mononuclear hematopoietic precursor cells of the monocyte/macrophage lineage. Their fusion and activity are complex processes finely regulated in balance with bone formation. Here, we focus on two proteins at the interface between actin cytoskeleton regulation and integrin-mediated adhesion: RIAM and Lamellipodin (LPD). We have accumulated highly novel results suggesting that RIAM and LPD exert uncoupled functions in OCLs, which opens new questions regarding their contribution to OCL pathophysiology. Using original transgenic mouse models generated by the consortium, the project will explore key steps in osteoclastogenesis and decipher the roles of RIAM and LPD in OCL fusion and activity, in the underlying rearrangements of OCL-specific adhesive actin structures, and in long and alveolar bone homeostasis in vivo. We will also validate our findings in human OCLs. Finally, the pathophysiological consequences of RIAM and LPD disruption will be studied in ovariectomized mice, a commonly accepted model of osteoporosis, as well as in a mouse model of periodontitis. Our consortium brings together experts in OCL biology, RIAM and LPD proteins, actin structures, and bone pathophysiology. By combining cutting-edge imaging technologies, transcriptomics, and functional assays, we will explore the functional properties of OCLs and their formation dynamics. This project will provide important and timely answers about the osteoclastogenesis process, including the coordination of each step. Given that altered OCL properties contribute to bone diseases, the impact of the project will be broadened as it has the potential to identify critical intervention points in mice to interfere with pathological bone loss.
